Women receiving fertility treatment are more likely to fall pregnant if they take certain dietary supplements, according to new research.
Experts at University College London recruited 58 subfertile women to take part in the study. They were split into two groups, with one receiving a dose of a branded supplement designed to aid conception—Pregnacare Conception—and the other given folic acid. After taking the pills for four weeks, all the women had ovulation induced using standard drugs.
The researchers found that the women taking the branded supplement were more than twice as likely to get pregnant than women taking the folic acid. In total, 60 percent of women taking Pregnacare Conception became pregnant (18 out of 30) compared with 25 percent of those taking the folic acid (11 out of 28).
The study, which was published in the journal Reproductive BioMedicine, will now be replicated in a larger trial.
Dr Rina Agrawal, a consultant and associate professor in reproductive medicine and obstetrics and gynecology at the University hospitals of Warwickshire and Warwick University, told the Press Association that the findings showed that taking a supplement was a clinical and cost-effective fertility treatment without any side effects.
She said she would “absolutely” recommend that women in the general population wishing to conceive take a pregnancy supplement. Vitabiotics, which makes Pregnacare, did not commission the research or provide a grant for it, she added.
The formula for Pregnacare Conception features mulivitamins, amino acids and trace minerals. For a complete list of ingredients and dosage levels, click here.
1 Agrawal, R. et al. Prospective randomised trial of multiple micronutrients, Reproductive BioMedicine Online December 2011.